3.4. After Inhibiting the MPO Activity, Vascular Endothelial Dysfunction in Hypercholesterolemic Rats Alleviated, and the Impaired Vascular NO/cGMP/cGK Pathway Improved. This evidence concerns the gene PRKG1 and endothelial dysfunction.